Frequency of data Quarterly collection Organisation Provider responsible for data collection Frequency of reporting Quarterly to commissioner Baseline period/date 2016/17 activity and outcomes Baseline value Enter the baseline value indicator Q4, 2017/18 period/date (on which payment is based) Final indicator value Introducing the agreed initiatives as set out in their plan (payment threshold) Rules for calculation of Payment to be based on achievement of in-year milestones. Evidence payment due at final (a lymphoedema improvement plan) must be produced at quarterly indicator period/date clinical quality review meetings for review. Payment is triggered based (including evidence to on % delivery of implementation plan. be supplied to commissioner) Final indicator 31 March 2018 reporting date Are there rules for any Yes If yes, please details agreed in-year in tables below. milestones that result in payment? Are there any rules for No partial achievement of the indicator at the final indicator period/date? Exit Route how Option A: As per TCST service specification, outcome indicators and – will the change an agreed selection of key performance indicators are included within 2018/19 Contract (Quality Requirements schedule). including any performance Option B: Using TCST service specification and progress made requirements be against the 17/18 CQUIN, a service development improvement plan is sustained once the agreed within 2018/19 contract (and includes clear milestones for CQUIN indicator has delivery with consequences of failure). been retired?
Frequency of data collection Quarterly Organisation responsible for data collection Provider Frequency of reporting to commissioner Quarterly Baseline period/date 2016/17 activity and outcomes Baseline value Enter the baseline value indicator period/date (on which payment is based) Q4, 2017/18 Final indicator value (payment threshold) Introducing the agreed initiatives as set out in their plan Rules for calculation of payment due at final indicator period/date (including evidence to be supplied to commissioner) Payment to be based on achievement of in-year milestones. Evidence (a lymphoedema improvement plan) must be produced at quarterly clinical quality review meetings for review. Payment is triggered based on % delivery of implementation plan. Final indicator reporting date 31 March 2018 Are there rules for any agreed in-year milestones that result in payment? Yes If yes, please details in tables below. Are there any rules for partial achievement of the indicator at the final indicator period/date? No Exit Route – how will the change including any performance requirements be sustained once the CQUIN indicator has been retired? Option A: As per TCST service specification, outcome indicators and an agreed selection of key performance indicators are included within 2018/19 Contract (Quality Requirements schedule). Option B: Using TCST service specification and progress made against the 17/18 CQUIN, a service development improvement plan is agreed within 2018/19 contract (and includes clear milestones for delivery with consequences of failure).
Template-business-case-lymphoedema-servicesFINAL.docx